Internal Medicine

An important new study on Statins in Diabetes provides clear evidence for primary cardiovascular disease (CVD) … New Study: Should All Patients with Diabetes Get Statins?Read more

An updated systematic review provides clarity on the efficacy and safety of cannabinoids for chronic pain … THC vs. CBD for Chronic Pain: What Clinicians Need to KnowRead more

The development of a new once-weekly HIV treatment regimen offers a significant step forward in managing … Once-Weekly HIV Pill: Efficacy Matches Daily Standard in Phase 2Read more

Once-weekly HIV treatment with the islatravir (ISL) and lenacapavir (LEN) combination shows strong potential to simplify … Once-Weekly Pill: A Breakthrough for HIV Treatment AdherenceRead more

The SURPASS-CVOT trial offers critical data comparing the cardiovascular safety of tirzepatide against dulaglutide in patients … Critical Trial Update: Tirzepatide vs. Dulaglutide for CV RiskRead more

Clinical guidelines recommend using Bisphosphonates for CRPS, but evidence supporting this treatment has been limited. A … Bisphosphonates for CRPS: Are They Safe and Effective?Read more

The landmark Women Informed to Screen Depending on Measures of Risk (WISDOM) randomised clinical trial provides … Is Risk-Based Screening the Future for Breast Cancer?Read more

Patients with HER2-positive early breast cancer and residual invasive disease after neoadjuvant therapy are at high … T-DXd Overthrows T-DM1 for High-Risk HER2+ Breast CancerRead more

The management of Patent Ductus Arteriosus (PDA) in extremely premature infants is a highly controversial topic … New Evidence: Why Expectant PDA Management is Safer for Preterm InfantsRead more

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are highly effective medications for treating type 2 diabetes and obesity. … GLP-1 Agonists & Cancer: The Latest Safety Data for DoctorsRead more